(Q45876186)

17 December 2017

title

Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins (English)

1 reference

17 December 2017

author name string

T Enkirch

1

1 reference

17 December 2017

S Kneissl

2

1 reference

17 December 2017

B Hoyler

3

1 reference

17 December 2017

G Ungerechts

4

1 reference

17 December 2017

W Stremmel

5

1 reference

17 December 2017

C J Buchholz

6

1 reference

17 December 2017

C Springfeld

7

1 reference

17 December 2017

publication date

5 January 2012

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

20

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

16-23

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2011.209

exact match

0 references

cites work

Gene therapy: twenty-first century medicine

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Viral vectors: from virology to transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Engineering targeted viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Paramyxovirus entry and targeted vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Antibody-targeted cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Therapeutic potential of oncolytic measles virus: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Targeted cell entry of lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Recent advances in lentiviral vector development and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Envelope targeting: hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Isolation and molecular characterization of a novel cytopathogenic paramyxovirus from tree shrews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

DARPins: an efficient targeting domain for lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

An oncolytic measles virus engineered to enter cells through the CD20 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

Rescue and propagation of fully retargeted oncolytic measles viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.209

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.209

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017